CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors
Anthony T. P. Chan, Sydney C. W. Tang
Kidney Res Clin Pract. 2022;41(6):682-698.   Published online July 19, 2022
DOI: https://doi.org/10.23876/j.krcp.21.285

Excel Download

Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors
Anthony T. P. Chan, Sydney C. W. Tang
Kidney Research and Clinical Practice. 2022;41(6):682-698   Crossref logo
Link1 Link2 Link3
MON-304 Effect of Sodium-Glucose Co-transporter 2 Inhibitors in Patients with Diabetic Kidney Disease
T. Takeda, A. Yoshino, S. Kawamoto
Kidney International Reports. 2019;4(7):S424   Crossref logo
Link1 Link2
WCN23-0237 THE EFFECT OF SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS ON RENAL FUNCTION AMONG DIABETIC KIDNEY DISEASE PATIENTS IN THAI POPULATION
P. KAEWDOUNGTIEN, T. Chirananthavat
Kidney International Reports. 2023;8(3):S189-S190   Crossref logo
Link1 Link2
Sodium–glucose linked transporter-2 inhibitors: potential for renoprotection beyond blood glucose lowering?
Richard E. Gilbert
Kidney International. 2014;86(4):693-700   Crossref logo
Link1 Link2
Renoprotective mechanisms of sodium‐glucose co‐transporter 2 (SGLT2) inhibitors against the progression of diabetic kidney disease
Sreenithya Ravindran, Shankar Munusamy
Journal of Cellular Physiology. 2021;237(2):1182-1205   Crossref logo
Link1 Link2 Link3
Sodium-glucose co-transporter-2 inhibitors in heart failure and chronic kidney disease: the role of empagliflozin
M. M. Batyushin
Russian Journal of Cardiology. 2021;26:4349   Crossref logo
Link1
POS-822 SODIUM-GLUCOSE CO-TRANSPORTER 2 INHIBITORS (SGLT2i); SHORT-TERM OUTCOME IN DIABETIC KIDNEY TRANSPLANT RECIPIENTS
J. Yagan, T. Mahmoud, O. Geith, N. El Serwey, M. Mustafa, S. Reda, P. Nair, T. AlOtaibi
Kidney International Reports. 2022;7(2):S354   Crossref logo
Link1 Link2
Sodium glucose co-transporter 2 inhibitors: blocking renal tubular reabsorption of glucose to improve glycaemic control in patients with diabetes
S. A. Jabbour, B. J. Goldstein
International Journal of Clinical Practice. 2008;62(8):1279-1284   Crossref logo
Link1 Link2
Comparative safety of sodium-glucose co-transporter 2 inhibitors in elderly patients with type 2 diabetes mellitus and diabetic kidney disease: a systematic review and meta-analysis
Yi Liu, Chuan An, Peilong Liu, Fan Yang, Quanlin Zhao
Renal Failure. 2023;45(1):   Crossref logo
Link1
Editorial: Sodium Glucose Co-Transporter 2 Inhibitors and Kidney Function
Daniel H. Van Raalte, Hiddo Lambers Heerspink
Frontiers in Pharmacology. 2022;13:   Crossref logo
Link1